Glaxo Expects a Shot of Growth in 2013: CEO
GlaxoSmithKline expects a return to growth in 2013 after the drugmaker's profits slipped in 2012 as austerity pricing in Europe continued to bite, CEO Andrew Witty told CNBC's "Squawk on the Street" on Wednesday.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here